MIRA INFORM REPORT

 

 

Report Date :

26.07.2011

 

IDENTIFICATION DETAILS

 

Name :

BIOGENTEK BG (INDIA) PRIVATE LIMITED

 

 

Registered Office :

106, Shahpuri Tirath Singh Tower, C-58, Community Centre, C Block, Janak Puri, New Delhi – 110 058

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

13.03.1998

 

 

Com. Reg. No.:

55-093006

 

 

Capital Investment / Paid-up Capital :

Rs.0.100 million

 

 

CIN No.:

[Company Identification No.]

U74130DL1998PTC093006

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of
Sensors Transducers and Weighing Scales Measuring Tapes.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (31)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 9000

 

 

Status :

Small Company

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a relatively small company in its field. Its scale of activities are limited. However, trade relations are reported as fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for small to mediocre business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

LOCATIONS

 

Registered Office :

106, Shahpuri Tirath Singh Tower, C-58, Community Centre, C Block, Janak Puri, New Delhi – 110 058, India 

Tel. No.:

91-11-25573125, 25513104

Fax No.:

91-11-25513106

E-Mail :

office@biogentek.com

ravindra@biogentek.com

Website :

http://www.biogentek.com

 

 

Branch Office :

Located at:

 

v      New Delhi

v      Chennai

v      Mumbai

v      Kolkata

v      Bangalore

v      Hyderabad

v      Trivandrum

v      Lucknow

v      Varanasi

v      Guwahati

 

 

DIRECTORS

 

As on 29.09.2010

 

Name :

Mr. Neeraj Pandey

Designation :

Director

Address :

C-8/8005, Vasant Kunj, New Delhi – 110 070, India

Date of Appointment :

30.03.1998

DIN No.:

01135827

 

 

Name :

Mr. Sanjay Gulati

Designation :

Director

Address :

GH9/204, Pachim Vihar, New Delhi – 110 063, India

Date of Appointment :

30.03.1998

DIN No.:

01135794

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 29.09.2010

 

Names of Shareholders

 

 

No. of Shares

Neeraj Pandey

 

5000

Sanjay Gulati

 

5000

Total

 

10000

 

As on 29.09.2010

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of
Sensors Transducers and Weighing Scales Measuring Tapes.

 

 

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

Corporation Bank, Janakpuri, New Delhi – 110 058, India

 

 

Facilities :

Secured Loans

31.03.2010

Rs. In Millions

31.03.2009

Rs. In Millions

Car loan from Banks

0.824

0.864

Total

0.824

0.864

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Rajendra Singh and Company

Chartered Accountants

Address :

S-3, Pankaj Central Market, IP Extension, Patparganj, New Delhi – 110 091, India

Income-tax PAN of auditor or auditor's firm :

AAQPS9850G

 

 

CAPITAL STRUCTURE

 

As on 31.03.2010

 

Authorised Capital :

No. of Shares

Type

Value

Amount

50000

Equity Shares

Rs.10/- each

Rs.0.500 million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

10000

Equity Shares

Rs.10/- each

Rs.0.100 million

 

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.100

0.100

0.100

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

2.222

1.272

0.896

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

2.322

1.372

0.996

LOAN FUNDS

 

 

 

1] Secured Loans

0.824

0.864

0.597

2] Unsecured Loans

0.000

0.000

0.000

TOTAL BORROWING

0.824

0.864

0.597

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

3.146

2.236

1.593

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

1.905

1.889

1.185

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.271

0.050

0.041

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

0.000

0.276

0.000

 

Sundry Debtors

1.360

0.316

0.733

 

Cash & Bank Balances

2.999

1.469

3.336

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

3.907

2.628

1.299

Total Current Assets

8.266

4.689

5.368

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

1.923

1.767

1.280

 

Other Current Liabilities

4.073

1.693

3.050

 

Provisions

1.300

0.932

0.671

Total Current Liabilities

7.296

4.392

5.001

Net Current Assets

0.970

0.297

0.367

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

3.146

2.236

1.593

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2010

31.03.2009

31.03.2008

 

SALES

 

 

 

 

 

Income

15.066

12.829

8.878

 

 

Other Income

 

 

 

 

 

TOTAL                                    

15.066

12.829

8.878

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

13.969

11.737

8.184

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

13.969

11.737

8.184

 

 

 

 

 

 

PROFIT BEFORE TAX

1.097

1.092

0.694

 

 

 

 

 

Less

TAX                                                     

0.147

0.716

0.370

 

 

 

 

 

 

PROFIT AFTER TAX

0.950

0.376

0.324

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

1.272

0.896

0.572

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

2.222

1.272

0.896

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

15.554

9.406

12.951

 

TOTAL EARNINGS

15.554

9.406

12.951

 

 

 

 

 

 

Earnings Per Share (Rs.)

95.02

37.64

32.41

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.2008

PAT / Total Income

(%)

6.31

2.93

3.65

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

10.79

16.60

10.59

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.47

0.80

0.70

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

3.50

3.83

5.62

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.13

1.07

1.07

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Note:

The registered office of the company has been shifted from 306, Shahpuri Tirath Singh Tower, C-58, Community Centre, C Block, Janak Puri, New Delhi – 110 058 to the present address w.e.f. 01.05.2011.

 

FORM 8:

 

Corporate identity number of the company

U74130DL1998PTC093006

Name of the company

BIOGENTEK BG (INDIA) PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

306, Shahpuri Tirath Singh Tower, C-58, Community Centre, C Block, Janak Puri, New Delhi – 110 058, India

E-Mail: ravindra@biogentek.com

This form is for

Creation of charge

Type of charge

Floating Charge

Particular of charge holder

Corporation Bank, Janakpuri, New Delhi – 110 058, India

E-Mail: 0522@corpbank.co.in

Nature of description of the instrument creating or modifying the charge

Limit agreement dated 28.12.2010

Date of instrument Creating the charge

28.12.2010

Amount secured by the charge

Rs.4.100 millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest:

Base Rate (8.25%) + 4.25 i.e. 12.5% p.a. at present subject to revision from time to time. The bank reserves the right to revise the rate of interest based on gradation or other reasons.

 

Terms of Repayment:

OD-running account repayable on demand subject to Annual renewal.

 

Margin:

Cash Margin 15%

Short particulars of the property charged

Officer Premises No. 8, IInd Floor, Kris Korner Commercial Plaza, Survey No. 176/9, 178/3 to 8, 179/4/1, 179/7, Village Kavesar, Opposite Swastik Residency, off. Ghodbunder, Thane (West) - Maharashtra - (India)

 

CONTINGENT LIABILITY:

 

Particulars

 

31.03.2010

(Rs. in millions)

Guarantees furnished by Bank remaining unexpired backed by personal guarantee of Directors of the Company and against which Fixed Deposit of the Company. Rs.1.497 millions are held as security.

1.822

 

 

FIXED ASSETS:

 

v      Furniture and Fixture

v      Car

v      Computer

v      Office Equipments

v      Cycle

v      Scooter

 

WEBSITE DETAILS:

 

PROFILE:

 

Subject, one of India's premier biotechnology enterprise, has been breaking new grounds in the field of biotechnology and microbiological research for over a decade now.

 

Ever since its inception, they at Subject, have truly been working with the philosophy of “Total Customer Satisfaction”, may it be by virtue of instrumentation supplied or the related after sales services rendered to their valued customers. For us, every user of ours has been a milestone achieved in their quest to excel in terms of support.

 

A dedicated team of their service personnel always in pursuit of excelling through their relentless efforts are available at the service at all times ,especially in situations, when the researcher or the production house is in need of some emergency assistance. It is noteworthy that such ready and timely support of ours is not just confined to the instrumentation / products supplied by us, but could also be extended to other makes as well.

 

Their association with their esteemed users over the years and their laudable and worthy suggestions henceforth have provided them  with the all necessary momentum to keep ourselves continually upgraded and be associated with remarkably high quality product lines from all over the Europe and the United States.

 

Their users both from the research community as also from the production enterprises have further inspired them  to develop certain innovative products within the country, which in due course will see their way through to the overseas markets as well.

 

Head quartered in New Delhi, Subject today has a well defined network of its own offices and personnel all over India.

 

While the company with its enduring and sustained endeavors would continue to enhance its impetus in the biotechnology business, due emphasis to keep pace with the dynamically changing requirements of the research and production community, especially the Biopharmaceutical World (where India is readying itself to face the challenges of the Patent regime) in the long term, emerges as the key anchor of their future growth
Their Vision is “to be one of the most avid and dependable associates in the field of biotechnological and microbiological research and production".

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.44.42

UK Pound

1

Rs.72.49

Euro

1

Rs.63.87

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

31

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.